Novel Susceptibility Locus at 22q11 for Diabetic Nephropathy in Type 1 Diabetes

• Maija Wessman ,

  * E-mail: maija.wessman@helsinki.fi (MW); per-henrik.groop@helsinki.fi (P-HG)

  Affiliations Folkhälsan Research Center, Folkhälsan Institute of Genetics, Biomedicum Helsinki, Helsinki, Finland, Biomedicum Helsinki, Research Program in Molecular Medicine and Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland

  ⨯
• Carol Forsblom,

  Affiliations Folkhälsan Research Center, Folkhälsan Institute of Genetics, Biomedicum Helsinki, Helsinki, Finland, Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Mari A. Kaunisto,

  Affiliations Folkhälsan Research Center, Folkhälsan Institute of Genetics, Biomedicum Helsinki, Helsinki, Finland, Biomedicum Helsinki, Research Program in Molecular Medicine and Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland

  ⨯
• Jenny Söderlund,

  Affiliations Folkhälsan Research Center, Folkhälsan Institute of Genetics, Biomedicum Helsinki, Helsinki, Finland, Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Jorma Ilonen,

  Affiliations Department of Clinical Microbiology, University of Eastern Finland, Kuopio, Finland, Immunogenetics Laboratory, University of Turku, Turku, Finland

  ⨯
• Riitta Sallinen,

  Affiliation Folkhälsan Research Center, Folkhälsan Institute of Genetics, Biomedicum Helsinki, Helsinki, Finland

  ⨯
• Tero Hiekkalinna,

  Affiliations Biomedicum Helsinki, Research Program in Molecular Medicine and Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland, Unit of Public Health Genomics, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Maija Parkkonen,

  Affiliations Folkhälsan Research Center, Folkhälsan Institute of Genetics, Biomedicum Helsinki, Helsinki, Finland, Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Alexander P. Maxwell,

  Affiliation Nephrology Research Group, Centre for Public Health, Queen's University of Belfast, Belfast, Northern Ireland, United Kingdom

  ⨯
• Lise Tarnow,

  Affiliation Steno Diabetes Center, Gentofte, Denmark

  ⨯
• Hans-Henrik Parving,

  Affiliations Department of Medical Endocrinology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Faculty of Health Science, Aarhus University, Aarhus, Denmark

  ⨯
• Samy Hadjadj,

  Affiliation Service de Médecine Interne, Endocrinologie et Maladies Métaboliques, Centre d'Investigation Clinique, Inserm CIC0802, CHU de Poitiers, Poitiers, France and Université de Poitiers, Poitiers, France

  ⨯
• Michel Marre,

  Affiliation Department of Endocrinology, Diabetology and Nutrition, Bichat-Claude Bernard University Hospital, Paris, France

  ⨯
• Leena Peltonen †,

  † Deceased.

  Affiliations Biomedicum Helsinki, Research Program in Molecular Medicine and Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland, Unit of Public Health Genomics, National Institute for Health and Welfare, Helsinki, Finland, Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hingston, United Kingdom

  ⨯
• Per-Henrik Groop ,

  * E-mail: maija.wessman@helsinki.fi (MW); per-henrik.groop@helsinki.fi (P-HG)

  Affiliations Folkhälsan Research Center, Folkhälsan Institute of Genetics, Biomedicum Helsinki, Helsinki, Finland, Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
•  [ ... ],
• on behalf of the FinnDiane Study Group
• [ view all ]
• [ view less ]